{
  "id": "additional_nodal_metastasis_nomogram",
  "title": "Additional Nodal Metastasis Nomogram",
  "description": "Predicts probability of additional non-sentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy",
  "category": "hematology",
  "version": "2003",
  "parameters": [
    {
      "name": "nuclear_grade",
      "type": "string",
      "required": true,
      "description": "Nuclear grade and tumor type",
      "options": ["ductal_i", "ductal_ii", "ductal_iii", "lobular"],
      "validation": {
        "enum": ["ductal_i", "ductal_ii", "ductal_iii", "lobular"]
      }
    },
    {
      "name": "lymphovascular_invasion",
      "type": "string", 
      "required": true,
      "description": "Presence of lymphovascular invasion (LVI)",
      "options": ["no", "yes"],
      "validation": {
        "enum": ["no", "yes"]
      }
    },
    {
      "name": "multifocal",
      "type": "string",
      "required": true,
      "description": "Multifocal tumor (cancer in multiple locations in breast)",
      "options": ["no", "yes"],
      "validation": {
        "enum": ["no", "yes"]
      }
    },
    {
      "name": "estrogen_receptor_status",
      "type": "string",
      "required": true,
      "description": "Estrogen receptor (ER) status",
      "options": ["negative", "positive"],
      "validation": {
        "enum": ["negative", "positive"]
      }
    },
    {
      "name": "negative_slns",
      "type": "integer",
      "required": true,
      "description": "Number of negative sentinel lymph nodes",
      "validation": {
        "min": 0,
        "max": 14
      }
    },
    {
      "name": "positive_slns",
      "type": "integer",
      "required": true,
      "description": "Number of positive sentinel lymph nodes",
      "validation": {
        "min": 0,
        "max": 7
      }
    },
    {
      "name": "pathologic_size",
      "type": "float",
      "required": true,
      "description": "Pathologic size of tumor in centimeters",
      "unit": "cm",
      "validation": {
        "min": 0,
        "max": 9
      }
    },
    {
      "name": "detection_method",
      "type": "string",
      "required": true,
      "description": "Method of detection of sentinel lymph node metastases",
      "options": ["ihc", "serial_he", "routine", "frozen"],
      "validation": {
        "enum": ["ihc", "serial_he", "routine", "frozen"]
      }
    }
  ],
  "result": {
    "name": "probability",
    "type": "float",
    "unit": "%",
    "description": "Probability of additional non-sentinel lymph node metastases"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 10,
        "stage": "Very Low Risk",
        "description": "Very low probability",
        "interpretation": "Very low probability (<10%) of additional non-sentinel lymph node metastases. Consider omitting completion axillary lymph node dissection."
      },
      {
        "min": 10,
        "max": 20,
        "stage": "Low Risk", 
        "description": "Low probability",
        "interpretation": "Low probability (10-20%) of additional non-sentinel lymph node metastases. Clinical decision-making should incorporate patient factors and preferences."
      },
      {
        "min": 20,
        "max": 50,
        "stage": "Moderate Risk",
        "description": "Moderate probability",
        "interpretation": "Moderate probability (20-50%) of additional non-sentinel lymph node metastases. Consider completion axillary lymph node dissection or axillary radiation therapy."
      },
      {
        "min": 50,
        "max": 100,
        "stage": "High Risk",
        "description": "High probability",
        "interpretation": "High probability (>50%) of additional non-sentinel lymph node metastases. Strong consideration for completion axillary lymph node dissection or axillary radiation therapy."
      }
    ]
  },
  "references": [
    "Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, Borgen PI, Cody HS 3rd, Kattan MW. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003 Dec;10(10):1140-51.",
    "Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol. 2005 Aug;12(8):654-9."
  ],
  "formula": "Linear predictor = β₀ + β₁(nuclear grade) + β₂(LVI) + β₃(multifocal) + β₄(ER status) + β₅(negative SLNs) + β₆(positive SLNs) + β₇(pathologic size) + β₈(detection method). Probability = exp(linear predictor) / (1 + exp(linear predictor))",
  "notes": [
    "This nomogram was developed and validated at Memorial Sloan Kettering Cancer Center",
    "Applies to breast cancer patients with positive sentinel lymph node biopsy",
    "Decision thresholds may vary by institution and should incorporate patient factors",
    "Modern practice often considers axillary radiation as alternative to completion dissection"
  ]
}